Skip to main content
. 2016 Mar 14;65(3):275–283. doi: 10.1538/expanim.15-0116

Table 2. A summary of the mutant mice produced using crRNA/tracrRNA with Cas9 mutants.

Locus Cas9 Trial Injected/2-cell Transferred Genotyped Mutated Monoallelic Biallelic Mosaic
Bcr nCas9 1 56/44 30 24 1 0 0 1
2 38/23 23 8 1 1 0 0
3 42/33 33 15 10 5 2 3

total 136/100 86 47 12 (25.5) 6 (50.0) 2 (16.7) 4 (33.3)

fCas9 1 36/26 26 21 0 0 0 0
2 43/24 24 13 7 1 3 3
3 39/26 26 11 1 0 0 1
4 39/30 30 14 9 5 1 3

total 157/106 106 59 17 (28.8) 6 (35.3) 4 (23.5) 7 (41.2)

Abl1 nCas9 1 134/118 60 39 8 (20.5) 2 (25.0) 1 (12.5) 5 (62.5)
fCas9 1 145/115 60 26 10 (38.5) 2 (20.0) 6 (60.0) 2 (20.0)

The numbers in parentheses in the “Mutated” columns represent the percentages calculated from the number of mutants relative to the number of genotyped embryos. The numbers in parentheses in the “Monoallelic”, “Biallelic” and “Mosaic” columns represent the percentages calculated from the number of each type relative to the number of “Mutated”.